DnB Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8M | Buy |
76,642
+15,114
| +25% | +$1.58M | 0.03% | 301 |
|
|
2025
Q1 | $7.18M | Sell |
61,528
-12,242
| -17% | -$1.43M | 0.03% | 312 |
|
|
2024
Q4 | $6.24M | Buy |
73,770
+67,626
| +1,101% | +$5.72M | 0.03% | 345 |
|
|
2024
Q3 | $552K | Buy |
6,144
+72
| +1% | +$6.47K | ﹤0.01% | 657 |
|
|
2024
Q2 | $489K | Buy |
6,072
+1,646
| +37% | +$132K | ﹤0.01% | 653 |
|
|
2024
Q1 | $353K | Buy |
+4,426
| New | +$353K | ﹤0.01% | 670 |
|